Free Trial

Short Interest in SelectQuote, Inc. (NYSE:SLQT) Decreases By 12.5%

SelectQuote logo with Finance background

SelectQuote, Inc. (NYSE:SLQT - Get Free Report) was the recipient of a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 2,030,000 shares, a drop of 12.5% from the April 30th total of 2,320,000 shares. Based on an average daily trading volume, of 1,490,000 shares, the short-interest ratio is currently 1.4 days. Approximately 1.5% of the shares of the company are sold short.

Institutional Trading of SelectQuote

A number of hedge funds have recently made changes to their positions in SLQT. Vanguard Group Inc. raised its position in SelectQuote by 7.0% during the first quarter. Vanguard Group Inc. now owns 7,880,173 shares of the company's stock valued at $26,320,000 after acquiring an additional 516,752 shares in the last quarter. Captrust Financial Advisors raised its position in SelectQuote by 5.0% during the fourth quarter. Captrust Financial Advisors now owns 1,542,010 shares of the company's stock valued at $5,736,000 after acquiring an additional 73,627 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. raised its position in SelectQuote by 62.0% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,251,828 shares of the company's stock valued at $4,181,000 after acquiring an additional 478,997 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in SelectQuote by 0.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,191,701 shares of the company's stock valued at $4,433,000 after acquiring an additional 10,038 shares in the last quarter. Finally, Northern Trust Corp raised its position in SelectQuote by 1.1% during the fourth quarter. Northern Trust Corp now owns 1,134,198 shares of the company's stock valued at $4,219,000 after acquiring an additional 11,957 shares in the last quarter. 34.59% of the stock is owned by hedge funds and other institutional investors.

SelectQuote Stock Performance

Shares of SLQT stock traded down $0.02 during trading hours on Thursday, reaching $2.17. The stock had a trading volume of 344,491 shares, compared to its average volume of 1,733,790. The company has a debt-to-equity ratio of 2.10, a current ratio of 6.36 and a quick ratio of 6.36. SelectQuote has a twelve month low of $1.62 and a twelve month high of $6.86. The firm has a 50-day simple moving average of $2.80 and a 200-day simple moving average of $3.49. The firm has a market capitalization of $374.80 million, a PE ratio of -24.11 and a beta of 1.11.

SelectQuote (NYSE:SLQT - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). SelectQuote had a negative net margin of 0.95% and a negative return on equity of 4.38%. The company had revenue of $408.16 million for the quarter, compared to analyst estimates of $412.83 million. As a group, equities analysts forecast that SelectQuote will post -0.07 earnings per share for the current year.

Analyst Upgrades and Downgrades

SLQT has been the subject of a number of recent analyst reports. Noble Financial raised SelectQuote to a "strong-buy" rating in a report on Wednesday, February 12th. Jefferies Financial Group began coverage on shares of SelectQuote in a research report on Wednesday, May 21st. They set a "hold" rating and a $2.75 target price for the company.

Read Our Latest Analysis on SLQT

SelectQuote Company Profile

(Get Free Report)

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.

See Also

Should You Invest $1,000 in SelectQuote Right Now?

Before you consider SelectQuote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.

While SelectQuote currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines